Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Risk factor analysis of screening data.

Begg CB.

J Chronic Dis. 1987;40(10):989-94. No abstract available.

PMID:
3301883
2.

Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.

Humphrey LL, Helfand M, Chan BK, Woolf SH.

Ann Intern Med. 2002 Sep 3;137(5 Part 1):347-60.

PMID:
12204020
3.

Efficacy of screening mammography for women in their forties.

Shapiro S.

J Natl Cancer Inst. 1994 Nov 16;86(22):1722; author reply 1722-5. No abstract available.

PMID:
7966402
4.
5.

Screening mammography for younger women: back to basics.

Sox H.

Ann Intern Med. 2002 Sep 3;137(5 Part 1):361-2. No abstract available.

PMID:
12204022
6.

Deficiencies in the analysis of breast cancer screening data.

Sickles EA, Kopans DB.

J Natl Cancer Inst. 1993 Oct 20;85(20):1621-4. No abstract available.

PMID:
8179650
7.

What is the relationship between breast cancer risk and mammography screening? A meta-analytic review.

McCaul KD, Branstetter AD, Schroeder DM, Glasgow RE.

Health Psychol. 1996 Nov;15(6):423-9.

PMID:
8973921
8.

Control of breast cancer. The why and how of mass screening.

Strax P.

Adm Radiol. 1989 Sep;8(9):30-6. No abstract available.

PMID:
10294843
9.
10.

The mammography dilemma: a crisis for evidence-based medicine?

Goodman SN.

Ann Intern Med. 2002 Sep 3;137(5 Part 1):363-5. No abstract available.

PMID:
12204023
11.

Sampling strategies in nested case-control studies.

Langholz B, Clayton D.

Environ Health Perspect. 1994 Nov;102 Suppl 8:47-51.

12.

The controversy over screening mammography.

Gifford DS.

Med Health R I. 2002 Mar;85(3):101-2. Review. No abstract available.

PMID:
11917742
13.

Breast cancer: screening and early detection.

Leitch AM.

Tex Med. 2001 Feb;97(2):74-8. Review.

PMID:
11233064
14.

The debate on breast cancer screening with mammography is important.

G√łtzsche PC.

J Am Coll Radiol. 2004 Jan;1(1):8-14. Review. No abstract available.

PMID:
17411511
15.

Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.

Warmerdam PG, de Koning HJ, Boer R, Beemsterboer PM, Dierks ML, Swart E, Robra BP.

J Epidemiol Community Health. 1997 Apr;51(2):180-6.

16.

Measuring mammography compliance: lessons learned from a survival analysis of screening behavior.

Partin MR, Casey-Paal AL, Slater JS, Korn JE.

Cancer Epidemiol Biomarkers Prev. 1998 Aug;7(8):681-7.

17.

The use of magnetic resonance imaging in breast cancer screening.

Lee CH, Weinreb JC.

J Am Coll Radiol. 2004 Mar;1(3):176-82. Review.

PMID:
17411555
18.

Risk factors in mass screening for breast cancer, multivariate analysis of data from the Cuban diagnosis pilot study.

Fern√°ndez L, Buch ML, Molina A, Carabelloso M, Gausioso R, Lage A.

Neoplasma. 1986;33(4):535-41.

PMID:
3762813
19.

The breast cancer screening controversy continues.

Logan-Young WW, Hoffman NY, Janus J.

Ann Intern Med. 1993 May 1;118(9):746-7; author reply 748-9. No abstract available.

PMID:
8460865
20.

Screening mammography may not be effective at any age.

Wilkerson BF, Schooff M.

J Fam Pract. 2000 Apr;49(4):302, 371. No abstract available.

PMID:
10778833
Items per page

Supplemental Content

Support Center